JINHAI MED TECH (02225.HK) expects an annual loss of approximately 18.1 million Singapore dollars.

On March 21, GELONGHUI reported that JINHAI MED TECH (02225.HK) announced the group is expected to record a net loss of approximately 18.1 million Singapore dollars for the year ending December 31, 2024, compared to a net loss of about 4.1 million Singapore dollars in the previous year. The Board of Directors believes the group's Business will show stable development in the fiscal year 2024. The group expects to achieve revenue of approximately 50.2 million Singapore dollars and a gross profit of about 11.4 million Singapore dollars for the fiscal year 2024, whereas the revenue for the fiscal year 2023 was about 45.6 million Singapore dollars and gross profit was approximately 12 million Singapore dollars.

Gelonghui FinanceMar 21 17:08

Jinhai Medical Technology Issues Profit Warning Amid Rising Expenses

TipRanksMar 21 17:07

JINHAI MED TECH: PROFIT WARNING

HKEXMar 21 17:00 · Announcements

JINHAI MED TECH (02225.HK) will hold a Board of Directors meeting on March 28 to consider and approve the annual performance.

Glory Exchange announced on March 14 that JINHAI MED TECH (02225.HK) will hold a Board of Directors meeting on March 28, 2025, aimed at considering and approving the announcement of the annual performance for the company and its subsidiaries for the year ending December 31, 2024, as well as the distribution of the final dividend (if applicable).

Gelonghui FinanceMar 14 17:18

JINHAI MED TECH: DATE OF BOARD MEETING

HKEXMar 14 17:00 · Announcements

GoFintech Innovation Sells Shares in Jinhai Medical Technology

MT NewswiresFeb 24 15:26